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Abstract  
AIM: The aim of our study was to identify chromosomal imbalances by whole-genome microarray-based 
comparative genomic hybridization (array CGH) in DNA samples of children in which karyotype results cannot be 
obtained. The present paper describes the first Albanian experience of an array CGH application.  
MATERIAL AND METHODS: The cohort included seven children with developmental delay or intellectual 
disability, facial dysmorphism and congenital anomalies according to clinical criteria, suggestive of chromosomal 
anomalies. The age range was from newborn to five years old. The cytogenetic analysis determined by a 
standard method of G-banding according to the International System for Human Cytogenetic Nomenclature (ISCN 
2005) was performed for all our patients, while array CGH was performed on genomic DNA isolated from the 
blood of 7 cases.  
RESULTS: Among the seven patients analysed with array CGH, three patients resulted in duplication and one 
deletion, one patient with a microdeletion and three patients with duplication. Array CGH facilitated the recognition 
of submicroscopic deletions and duplications as risk factors for genetic diagnosis in all our patients.  
CONCLUSIONS: Our case series with congenital chromosomal anomalies confirms the high diagnostic value of 
the method, as suggested by previous studies. The technique must be available also in less developed countries, 
to significantly improve the genetic diagnosis of paediatric patients with developmental delay or intellectual 
disability, congenital anomalies and dysmorphic features. The identification of chromosomal abnormalities in 
these patients and the genetic counselling will provide family members with an explanation for their child’s 
developmental disability or birth defect, allowing better information about recurrence risks, and permit the 
anticipation of certain medical problems that require intervention. 
 
 
 
 
 
 
Introduction 
 
Laboratory evaluation of patients with 
developmental delay/intellectual disability, congenital 
anomalies and dysmorphic features has changed 
significantly in the last years with the introduction of 
microarray technologies [1].  
Array Comparative Genomic Hybridization 
(array CGH) is rapidly becoming the first tier clinical 
genetic test for patients with developmental 
delay/intellectual disability and multiple congenital 
anomalies. Numerous studies have demonstrated that 
array CGH offers a much higher diagnostic yield for 
this group of patients in respect to conventional 
karyotyping with a G-banded karyotype [2]. This 
increased resolution of microarray technology over 
conventional cytogenetic analysis allows for 
identification of chromosomal imbalances with greater 
precision, accuracy, and technical sensitivity, primarily 
because of its higher sensitivity for sub-microscopic 
deletions and duplications.  
The aim of our study was to identify 
chromosomal imbalances by array CGH in DNA 
samples of children in which karyotype results cannot 
be obtained. We describe the first Albanian 
experience from a cohort of 7 children with 
developmental delay or intellectual disability, 
congenital anomalies and dysmorphic features, 
according to clinical criteria. 
 
Material and Methods 
The cohort included seven children with 
developmental delay/intellectual disability, congenital 
anomalies and dysmorphic features, according to 
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clinical criteria, suggestive of chromosomal 
anomalies. The age range was from newborn to five 
years old. The case series has only a small number of 
cases because array CGH is not yet performed in 
Albania.  
The cytogenetic analysis, as determined by a 
standard method of G banding according to the 
International System for Human Cytogenetics 
Nomenclature (ISCN 2013), was performed in all our 
patients; while array CGH according to the 
International Standard Cytogenomic Array (ISCA) 
Consortium statement 2010 was performed on 
genomic DNA isolated from the blood of 6 cases. All 
patients were scored using a clinical scoring system. 
Written informed consent was obtained from the 
parents of all children.  
  
DNA isolation and Array CGH 
Blood samples with EDTA were collected 
from peripheral blood of patients. DNA extraction was 
carried out using the Qiagen QIAamp
®
 DNA blood 
mini kit (QIAGEN, Valencia, CA, USA). Array-CGH 
analysis was performed using 4 × 44 K, 2 × 105 K and 
4 × 180 K commercial arrays (Agilent Technologies, 
Santa Clara, CA, USA) according to the 
manufacturer's instructions. This platform contains 60-
mer oligonucleotide probes spanning the entire 
human genome with an overall median probe spacing 
of 22 Kb (19 Kb in Refseq genes). After hybridization, 
the arrays were scanned in a dual-laser scanner (DNA 
Microarray Scanner with Sure Scan High-Resolution 
Technology, Model G2565CA; Agilent Technologies) 
and the images were extracted and analysed through 
Agilent Feature Extraction software (v10.5.1.1) and 
DNA Analytics software (v4.0.73), respectively. 
Fluorescence in situ hybridization (FISH) analysis was 
performed to confirm the results of array-CGH and the 
mode of inheritance.  
 
 
Results  
 
All seven patients with suggestive features of 
a chromosomal anomaly had been analysed by 
conventional karyotyping by standard GTG banding 
(550 band resolution per haploid karyotype). Most of 
the patients had an apparently normal karyotype, or in 
some cases, the karyotype analysis did not yield 
significant results. In these patients, the detection of 
gains or losses of genetic material were small to be 
detectable by standard G-banded chromosome, and 
array CGH method was applied.  
The blood sample of one patient, not included 
in this case series (findings from this patient are not 
described in Table one), was analysed only with 
conventional karyotyping. GTG banding revealed a 
karyotype 46, XY, del (7) (q21q22.2). He was a 
newborn boy with dysmorphic facial features, bilateral 
limbs ectrodactyly, growth retardation and 
developmental delay. His karyotype was 46, XY, del 
(7) (q21-q22.2), with one interstitial deletion of 
chromosome 7. The deletion was de novo because 
the parental karyotype was normal. Syndromic 
ectrodactyly is expressed as an autosomal dominant 
trait with reduced penetrance and variable expression. 
Several studies have pointed out the probable role of 
three genes present in this region, DLX5, DLX6 and 
DSS1 genes, in limb development [3]. 
Among the seven patients of our case series 
(Table 1) analysed with karyotype and array CGH, 
three patients resulted with duplication and a deletion 
(cases 2, 3, 7); 3 patients with a duplication (cases 1, 
5, 6) and one patient with a deletion (case 4). The 
results were confirmed by FISH analysis. Clinical 
information, karyotype and array-CGH results of our 
patients are summarised in Table 1. For all patients, 
karyotype and FISH analysis has been extended to 
parental samples, so to establish if an aberration was 
inherited or de novo. In 2 out of the seven patients, 
the chromosomal aberration had been inherited from 
one of the healthy parents who were carriers of 
balanced reciprocal translocation.  
One male patient (case 2) with karyotype 46, 
XY, der (21), was diagnosed with a duplication 
involving 16p13.3-16p13.2, which spans a region of 
about 8, 7 Mb and deletion involving 21q23.3-21q22.3 
of about 280,8Kb. The duplication was confirmed by 
FISH analysis using locus specific probe 16pter that 
has confirmed the derivative material of chromosome 
16 in the terminal end of the long arm of rearranged 
chromosome 21. This rearrangement was the result of 
an unbalanced translocation between the short arm of 
a chromosome 16 and the long arm of a chromosome 
21. A balanced translocation t (16; 21) (p13.3-13.2; 
q23.3-22.3) inherited from a healthy mother was found 
by FISH analysis.  
Another case, a male patient (case 7) with 
karyotype 46, XY, der (4), showed a duplication 
involving 4q27 and a deletion involving 21q22. FISH 
analysis using specific probes confirmed an 
unbalanced translocation between the subtelomeric 
region of the long arm of a chromosome 4 and the 
subtelomeric region of the short arm of a chromosome 
21. A balanced translocation t (4; 21) (q27; q22) 
inherited from a healthy father was found by FISH 
analysis.  
It is important to emphasise that these 
parents were phenotypically normal and all 
translocations were balanced. The other chromosomal 
rearrangements which were observed in the 
remaining patients were a de novo occurrence.  
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Table 1: Clinical information, karyotype and array-CGH results 
of our patients 
Case/ 
No 
Gender 
Array-CGH 
results 
Karyotype 
results 
Origin 
Estimated 
size 
Clinical features 
1 M dup(10)(q22) 
46, XY, 
dup(10)(q22) 
de novo 6 Mb 
moderate mental 
retardation, hypotonia, 
microcephaly, 
epicanthus, low-set, 
misshapen ears with 
overfolding of angulated 
upper helix, relatively 
short metatarsals and 
phalanges and 
hypoplasia of 
midphalanx of the fifth 
finger with clinodactyly 
of both feet 
2 M 
dup 16p13.3-
16p13.2 
del 21q23.3-
21q22.3 
46, XY, der 
(21) 
maternal 
8,7 Mb 
280,8Kb 
micrognathia, 
labioschisis, 
hypospadias, congenital 
heart disease and pes 
equinovarus 
3 F 
dup 
7p22.37p21.2 
del 
9p24.3p24.1 
46, XY, der 
(9) 
de novo 
5,1 Mb 
4 Mb 
delayed psychomotor 
development, 
trigonocephaly, broad 
flat nasal bridge, 
epicanthus, anteverted 
nares, malformed 
external ears, 
hypertelorism, 
omphalocele, 
palatoschisis 
4 F 
del 22q11.1- 
q11.21 
46, XX de novo 2,5 Mb 
congenital heart 
disease 
5 F 
dup 7p22.3-
p22.1 
46, XX, 
der(20) 
de novo 4,2 Mb 
microphthalmia, ocular 
hypertelorism and low-
set ears 
6 F dup 1p36.33 46, XX de novo 3,9 Mb 
psychomotor delay, 
trigonocephaly, 
microcephaly, 
epicanthus, 
hypertelorism, wide 
nose, convergent 
strabismus, and spastic 
cerebral palsy 
7 M 
dup 4q27 
del subtle 
21q22 
46, XY, der 
(4) 
paternal 
750Kb 
1 Mb 
dysmorphic facial 
features, complex heart 
disorder and 
cryptorchidism 
 
 
 
Discussion 
 
In this study, the array-CGH analysis yielded 
more results than did karyotype analysis, provided 
better detection of genetic abnormalities and a better 
opportunity for genotype/phenotype correlations. We 
used DNA oligonucleotides to analyse other patients 
by array CGH, where the chromosomal abnormality 
was suspected due to the combination of clinical 
features. Five of the observed chromosomal 
aberrations were de novo, and two aberrations were 
inherited from one of the phenotypically normal 
parents (cases 2, 7 in Table 1). In the setting of 
multiple anomalies, a balanced translocation in one of 
the parents could be the explanation for unbalanced 
offspring, and G-banded karyotyping should still be 
the standard of care for this indication. In the clinical 
setting, probands are more likely to carry an 
imbalance, and parents or other family members 
would subsequently be tested through traditional 
cytogenetic methods [3, 4]. 
The first patient (Case one in Table 1) was a 
boy five years old with moderate mental retardation, 
hypotonia, microcephaly, epicanthus, low-set, 
misshapen ears with overfolding of angulated upper 
helix, relatively short metatarsals and phalanges and 
hypoplasia of midphalanx of the fifth finger with 
clinodactyly of both feet. His karyotype was 46, XY, 
dup (10) (q22) with one duplication of the long arm of 
chromosome 10. The range and severity of symptoms 
and physical findings in dup (10) (q22) may vary from 
person to person, depending upon the exact length 
and location of the duplicated portion of chromosome 
10q. The previous studies have reported that the use 
of array-CGH would provide an insight of genetic 
abnormality [5].  
The second patient was a newborn boy, who 
presented a facial dysmorphic phenotype with 
micrognathia, labioschisis, hypospadias, congenital 
heart disease and pes equinovarus. The high-
resolution G-banding, revealed a karyotype with 46 
chromosomes, XY chromosome complement and a 
structurally abnormal chromosome 21. Array-CGH 
revealed one 8, 7 Mb duplication in the short arm of 
chromosome 16, involving 16p13.3-16p13.2 and a 
280, one 8 Kb deletion in the long arm of chromosome 
21, involving 21q23.3-21q22.3. These anomalies were 
inherited from his mother who had a balanced 
translocation (16; 21) with 46, XX, der (21) t (16; 21) 
(p13.3-13.2; q23.3-22.3) karyotype. Previous studies 
have suggested that the CREBBP gene was dosage 
sensitive, and also responsible for the phenotype of 
chromosome 16p13.3 duplication syndrome. 
Chromosome 16p13.3 duplication syndrome is due to 
the duplication of chromosome 16p13.3; 
encompassing the CREBBP gene and characterised 
by frequent clinical findings such as mild to moderate 
intellectual disability, facial dysmorphism, anomalies 
of the extremities, and occasional developmental 
defect of the eyes, palate, genitalia, and heart (OMIM 
613458). Both the genotype and phenotype of our 
case overlapped with chromosome 16p13.3 
duplication syndrome, suggesting that the duplication 
of 16p13.3 was the pathogenic copy number variation 
(CNV) in our case and the CREBBP gene was the 
most critical candidate gene responsible for the 
phenotype of this patient [6]. 
The third patient was a female; one-year-old 
presented delayed psychomotor development, 
trigonocephaly, broad flat nasal bridge, epicanthus, 
anteverted nares, malformed external ears, 
hypertelorism, omphalocele, and palatoschisis. Her 
cytogenetic analysis revealed 46, XX, der (9) 
karyotype; but array CGH identified a 5, 1 Mb 
duplication involving 7p22.3-p21.2 and a deletion 
involving a 9p24.3-p24.1 region of about 4 Mb. This 
rearrangement was the result of an unbalanced 
translocation between the short arm of a chromosome 
7 and the short arm of chromosome 9, confirmed by 
FISH analysis. The presence of craniofacial 
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dysmorphism, trigonocephaly, prominent forehead, 
anteverted nostrils with long philtrum, psychomotor 
retardation, and congenital malformations such as 
omphalocele and cardiopulmonary anomalies should 
alert clinicians to the possibility of deletion 9p 
syndrome and refer such patients for cytogenetic 
confirmation, as in our case. Cytogenetic analysis is 
vital as it aids in the precise and early diagnosis of this 
syndrome and helps to exclude other causes and 
provide appropriate genetic counselling [7]. 
The fourth patient was a girl, two months old, 
with congenital heart disease (interrupted aortic arch). 
Her cytogenetic analysis revealed a normal karyotype 
46, XX; but array CGH identified a 2, 5 Mb deletion 
located in 22q11.1-q11.2, that encompassed 12 
HGNC genes (Hugo Gene Nomenclature Committee) 
and 10 OMIM genes (Online Mendelian Inheritance in 
Man). This microdeletion determines DiGeorge 
syndrome. Although the genes responsible for the 
clinical features associated with 22q11.2 distal 
deletion syndrome have not been clearly defined, 
several potential candidate genes have been 
suggested. CRKL and MAPK1 genes have been 
suggested to play a role in the heart anomalies that 
are common in 22q11.2 distal deletion syndrome. 
MAPK1 has also been suggested to be associated 
with placental development. Therefore, having one 
copy of this gene missing in 22q11.2 distal deletion 
syndrome may be linked to the tendency for 
premature birth and intrauterine growth restriction. 
The MAPKI gene in mice has been shown to 
contribute to social behaviour and therefore may play 
a role in the behavioural problems found in some 
people with 22q11.2 distal deletion syndrome [8].  
The fifth patient was a girl four months old 
presented microphthalmia, ocular hypertelorism and 
low-set ears. Her cytogenetic analysis revealed a 
euploid karyotype with the extra chromosomal 
material in the telomeric area of the short arm of 
chromosome 20 with 46, XX, der (20) karyotype. 
Array CGH identified a duplication involving 7p22.3-
p21.2 of about 4, 2 Mb. There are some reports of 
patients with duplications that include overlapping 
chromosomal sub-domains. 7p22.1 duplication 
syndrome is described in the literature, and speech 
delay with recognisable facial features is observed in 
these patients. The described duplication is 
approximately 1.7 Mb and fifteen genes are involved 
in the duplicated segment [9]. 
The sixth patient was a girl, seven-month-old 
presented psychomotor delay, trigonocephaly, 
microcephaly, epicanthus, hypertelorism, wide nose, 
convergent strabismus, and spastic cerebral palsy. 
Her cytogenetic analysis revealed a normal karyotype 
46, XX; but array CGH identified an extra 
chromosomal material in the short arm of 
chromosome 1, dup1p36.33. Few cases of 1p36 
duplications have been reported, and data regarding 
the genotype-phenotype correlations are emerging. 
The phenotype includes intellectual disability, 
developmental delay, feeding difficulties, hyperactivity 
and seizures. The distal duplication region contains 
the putative gene for epilepsy, KCNAB2, and the 
MMP 23A and B genes. Overexpression of MMP 23A 
and B genes has been proposed as possible 
candidate genes for craniosynostosis [10-12]. 
The seventh patient was a boy, one-month-
old, with dysmorphic features, complex heart disorder 
and cryptorchidism. His karyotype resulted 46, XY, 
der (21) t (4; 21) (q27; q22). Array CGH revealed 
duplication at 4q27q35 and a deletion 21q22. This 
rearrangement was the result of one balanced 
translocation between the long arm of chromosome 4 
and the distal area of the long arm of chromosome 21, 
exactly in 4q27 and 21q22 that were inherited from his 
healthy father. Partial trisomy distal 4q is a rare 
chromosomal disorder, commonly characterised by a 
low birth weight and growth deficiency. About fifty 
percent of cases suffering from this syndrome also will 
have heart defects and vascular abnormalities. 
According to reports in the medical literature, severe 
cardiac and/or renal defects may lead to potentially 
life-threatening complications in some cases [13].  
Genetic counselling about the risk of an 
unbalanced offspring in the future pregnancies was 
considered in dealing with the parents. The 
identification of chromosomal abnormalities provided 
family members with an explanation for their child’s 
developmental disability or birth defect allowed for 
better information about recurrence risks and 
permitted the anticipation of certain medical problems 
that may require intervention.  
We may conclude that the emergence of 
array CGH as a diagnostic tool in molecular genetics 
has facilitated recognition of submicroscopic deletions 
and duplications as risk factors for genetic diagnosis 
in all our patients. This analysis allowed for a higher 
rate of detection the chromosomal anomalies and this 
determination is especially valuable in patients with 
congenital anomalies of unknown aetiology, or in 
cases in which karyotype results cannot be obtained. 
It can be used in the first-line investigation as a 
practical and scientific value and has improved 
significantly the genetic diagnosis of paediatric 
patients with developmental delay/intellectual 
disability, congenital anomalies and dysmorphic 
features. 
In conclusion, clarification of the genetic 
profile generated by array-CGH analysis may result in 
detailed follow-ups and, in the long-term, a better 
overall outcome for these patients. The short-term 
perspective allows for family counselling and prenatal 
diagnosis.  
We have reported a small number of cases 
with congenital chromosomal anomalies and 
confirmed the high diagnostic value of the previous 
studies. It is important that the technique becomes 
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available also in less developed countries improving 
significantly the genetic diagnosis of paediatric 
patients with developmental delay/intellectual 
disability, congenital anomalies and dysmorphic 
features. 
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